Clever Leaves Partners with SOMAÍ Pharmaceuticals and Sends First Commercial Shipments to Portugal
25 5월 2023 - 9:30PM
Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW), a global
medicinal cannabis company, announced today that it has entered
into a five-year agreement with SOMAÍ Pharmaceuticals, to supply
its operations in Portugal with EU-GMP certified CBD extracts from
Colombia.
With the first shipments under the agreement
already completed, Clever Leaves will continue to supply EU-GMP
pharmaceutical-grade APIs and CBD extracts, produced in the
Company’s facility in Colombia, to SOMAÍ for further processing
into finished products for patients across Europe. Positioned to be
one of the largest players in Europe’s medical cannabis market,
SOMAÍ’s goal is to design new dosage forms that deliver consistent
quantities of active ingredients to patients by going beyond
conventional drug delivery systems. These are the first commercial
shipments Clever Leaves has sent to Portugal, adding to the more
than 15 countries that Clever Leaves has exported to from its
European Union Good Manufacturing Practices (EU-GMP) certified
facility in Colombia.
“By combining our expertise in producing and
developing high-quality pharmaceutical-grade products with SOMAÍ's
innovative approach to drug delivery systems, we aim to streamline
patient access to pharmaceutical-grade cannabis products throughout
Europe. This collaboration signifies Clever Leaves’ commitment to
shaping the future of the global medical cannabis industry and
grows our position in Europe's rapidly expanding medical cannabis
market,” said Andres Fajardo, CEO and Co-Founder of Clever
Leaves.
“SOMAÍ Pharmaceuticals embarked on an extensive
quest to seek a formidable partner to launch one of the most
comprehensive cannabis product lines for the flourishing European
markets. We are proud to be working with the highly professional
Clever Leaves team and are most impressed with the high-quality
EU-GMP CBD extract. We look forward to further collaborations with
Clever Leaves to propel our product lines with even more advanced
formulations and delivery methods,” said Michael Sassano, CEO and
Founder of SOMAÍ Pharmaceuticals.
Having recently received its fifth GMP
certification, Clever Leaves is the first and only medicinal
cannabis company globally with GMP certifications from the EU,
Colombia, and Brazil. Clever Leaves has the ability to ship
high-quality pharmaceutical-grade products from its world-class
facility in Colombia that meets all regulatory standards throughout
Europe.
About Clever Leaves Holdings
Inc.Clever Leaves is a global medicinal cannabis company.
Its operations in Colombia produce cannabinoid active
pharmaceutical ingredients (API) and finished products in flower
and extract form to a growing base of B2B customers around the
globe. Clever Leaves aims to disrupt the traditional cannabis
production industry by leveraging environmentally sustainable,
ESG-friendly, industrial-scale, and low-cost production methods
with the world’s most stringent pharmaceutical quality
certifications. For more information, please
visit https://cleverleaves.com/en/home/
Press Contacts:Maria
PetsanasKCSA Strategic Communicationscleverleaves@kcsa.com +1
917-692-6673
Commercial Contact:Andrew
MillerHead of Global Business
DevelopmentAndrew.miller@cleverleaves.com+1 416-817-1336
About SOMAÍ Pharmaceuticals
Ltd. SOMAÍ Pharmaceuticals is a large-scale
manufacturer of cannabis products concentrating on the highest
quality medical-grade pharmacological applications. The company
invests in the extraction, research, development, formulation, and
distribution of EU GMP-pharmaceutical market-authorized cannabinoid
products. SOMAÍ is committed to revolutionizing healthcare through
cannabis-based treatments. For more information, please visit
SOMAÍ’s website. You can read SOMAÍ’s and CEO Michael Sassano’s
articles here.
Press Contacts:Nataliia
GarninaMarketing Manager+351 963 551 216ng@somaipharma.eu
Commercial Contact:George
BellowChief Operational OfficerGeorge@somaipharma.eu +33 6 5245
6201
Clever Leaves (NASDAQ:CLVRW)
과거 데이터 주식 차트
부터 8월(8) 2024 으로 9월(9) 2024
Clever Leaves (NASDAQ:CLVRW)
과거 데이터 주식 차트
부터 9월(9) 2023 으로 9월(9) 2024